Exact Sciences Prices Stock Offering of 10M Shares | GenomeWeb

NEW YORK (GenomeWeb News) – Exact Sciences today priced its common stock offering of 10 million shares at $12.75 per share.

The Madison, Wis.-based molecular diagnostics firm expects net proceeds from the offering to be around $119.7 million. However, the underwriters of the offering have a 30-day option to purchase up to an aggregate of 1,500,000 additional shares of common stock.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.